De Novo device
Banyan BTI
Banyan Biomarkers, Inc. · Brain Trauma Assessment Test (QAT, Class II) · First FDA decision Feb 14, 2018, newest Feb 14, 2018Traumatic brain injury and concussion
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "Banyan BTI"
MAUDE reports
0
Brand "Banyan BTI", since 2015
PubMed studies
0
Mentioning "Banyan BTI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Banyan BTI
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Banyan BTINew device typeBreakthroughDe Novo
DEN170045 · Decided Feb 14, 2018 · 170 days after receipt
Device type: Brain Trauma Assessment Test (QAT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Banyan BTI", any status and sponsor, newest update first.
No registered device study names "Banyan BTI".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Banyan BTI", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QAT
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Banyan BTI"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QAT.
- Vidas Tbi (Gfap, UCH-L1)bioMerieux, Inc. · 510(k) 2024
- i-STAT TBI Cartridge with the i-STAT Alinity SystemAbbott Point of Care · 510(k) 2024
- TbiAbbott Laboratories · 510(k) 2023
- Traumatic brain injury (TBI) testAbbott Laboratories · 510(k) 2023
- i-STAT TBI Plasma cartridge with the i-STAT Alinity SystemAbbott Laboratories · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.